Clinical Trial Update: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inotuzumab ozogamicin with frontline chemotherapy for newly diagnosed B-ALL in young adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-acute Lymphoblastic Leukemia

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: B Acute Lymphoblastic Leukemia | Phase 3 | Status: RECRUITING